| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
3.53 0.28 (0.09%) |
09-21 11:17 |
|
Open: |
3.3 |
Pre close: |
3.25 |
Target:
|
4.09 
|
|
High: |
3.645 |
Low: |
3.2101 |
Resistance:
|
3.50
4.09
|
|
Volume: |
198,540 |
Market Cap: |
14M |
Support:
|
2.77
2.32
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.15
|
MACD |
MACD(12,26):
|
0.21 |
|
MA(20): |
2.80 |
Signal(12,26,9): |
0.15 |
|
MA(100): |
2.39 |
Stochastic Oscillator |
%K(14,3):
|
85.67 |
|
MA(250): |
2.83 |
%D(3): |
78.05 |
|
Average Volume(K) |
3-Month: |
7523
|
52-Week |
High:
|
5.88 |
|
10-Days: |
11584 |
Low: |
1.55 |
|
RSI |
RSI(14):
|
69.93 |
Change(%): |
7.4 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-162.0 |
Shares Out. (M) |
3.92 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-143.3 |
Shares Float (M) |
3.78 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.70 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.20 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
164 |
|
Book Value (p.s.) |
5.300 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.65 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.25 |
P/S |
170030000.00 |
|
Operating Margin |
-2622.85 |
Levered Free Cash Flow
(M) |
-3.37 |
P/CF |
-2.18 |
|
|
|
|
|
|
